Cargando…

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 enters the host by infecting nasal ciliated cells. Then, the virus can spread towards the oropharyngeal cavity and the pulmonary tissues. The antiviral adaptive immunity is promptly induced in response to the virus’s detection, with virus-sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrantelli, Flavia, Manfredi, Francesco, Chiozzini, Chiara, Leone, Patrizia, Pugliese, Katherina, Spada, Massimo, Di Virgilio, Antonio, Giovannelli, Andrea, Valeri, Mauro, Cara, Andrea, Michelini, Zuleika, Andreotti, Mauro, Federico, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535545/ https://www.ncbi.nlm.nih.gov/pubmed/37766110 http://dx.doi.org/10.3390/vaccines11091433

Ejemplares similares

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)

The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2021)

Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
por: Ferrantelli, Flavia, et al.
Publicado: (2020)

N-Terminal Fatty Acids of NEF(MUT) Are Required for the CD8(+) T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2020)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
por: Ferrantelli, Flavia, et al.
Publicado: (2019)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor
por: Cavani, Maurizio, et al.
Publicado: (2022)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Rodriguez, Jorge H.
Publicado: (2021)

Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
por: Sabbatucci, Michela, et al.
Publicado: (2015)

Erratum to: Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
por: Sabbatucci, Michela, et al.
Publicado: (2015)

Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice
por: Negri, Donatella R. M., et al.
Publicado: (2010)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2020)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice
por: Muturi, Elishiba, et al.
Publicado: (2022)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction
por: Chaudhuri, Dwaipayan, et al.
Publicado: (2022)

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
por: DeDiego, Marta L., et al.
Publicado: (2008)

COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice
por: Zheng, Jian, et al.
Publicado: (2020)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
por: Moreau, Gregory Brett, et al.
Publicado: (2020)

Genetic variability of human angiotensin‐converting enzyme 2 (hACE2) among various ethnic populations
por: Li, Quan, et al.
Publicado: (2020)

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
por: Linsky, Thomas W., et al.
Publicado: (2020)

The Infection and Pathogenicity of SARS-CoV-2 Variant B.1.351 in hACE2 Mice
por: Chen, Qi, et al.
Publicado: (2021)

The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)

Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
por: Vidal, Enric, et al.
Publicado: (2021)

Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

Protocol for infecting and monitoring susceptible k18-hACE2 mice with SARS-CoV-2
por: Couto, Joana, et al.
Publicado: (2023)

Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication
por: Le Chevalier, Fabien, et al.
Publicado: (2023)

Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2
por: Glazkova, D. V., et al.
Publicado: (2022)

HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8(+) T Cell-Mediated Immune Response
por: Di Bonito, Paola, et al.
Publicado: (2015)

Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)

COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
por: Mittal, Anshumali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9th8n0l18tabrbvmsie34bouas